Gwendolyn Wrenn Baxter

Array ( [id] => 7074346 [patent_doc_number] => 20050147614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Antibodies against tumor surface antigens' [patent_app_type] => utility [patent_app_number] => 10/609671 [patent_app_country] => US [patent_app_date] => 2003-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 25153 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20050147614.pdf [firstpage_image] =>[orig_patent_app_number] => 10609671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7437716 [patent_doc_number] => 20040266993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Non-immunoglobulin binding polypeptides' [patent_app_type] => new [patent_app_number] => 10/611655 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20842 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266993.pdf [firstpage_image] =>[orig_patent_app_number] => 10611655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 464315 [patent_doc_number] => 07238786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'Monoclonal antibody cPAM4' [patent_app_type] => utility [patent_app_number] => 10/461878 [patent_app_country] => US [patent_app_date] => 2003-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 27042 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238786.pdf [firstpage_image] =>[orig_patent_app_number] => 10461878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122378 [patent_doc_number] => 20050014207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Monoclonal antibody hPAM4' [patent_app_type] => utility [patent_app_number] => 10/461885 [patent_app_country] => US [patent_app_date] => 2003-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 30031 [patent_no_of_claims] => 155 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014207.pdf [firstpage_image] =>[orig_patent_app_number] => 10461885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395363 [patent_doc_number] => 20040022726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Methods and compositions for intravesical therapy of bladder cancer' [patent_app_type] => new [patent_app_number] => 10/448327 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11250 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022726.pdf [firstpage_image] =>[orig_patent_app_number] => 10448327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 486740 [patent_doc_number] => 07217796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-15 [patent_title] => 'Neutralizing human anti-IGFR antibody' [patent_app_type] => utility [patent_app_number] => 10/443466 [patent_app_country] => US [patent_app_date] => 2003-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25368 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/217/07217796.pdf [firstpage_image] =>[orig_patent_app_number] => 10443466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825247 [patent_doc_number] => 20030235869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Biological products' [patent_app_type] => new [patent_app_number] => 10/428408 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 9284 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20030235869.pdf [firstpage_image] =>[orig_patent_app_number] => 10428408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825246 [patent_doc_number] => 20030235868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Antibodies specific for mucin polypeptide' [patent_app_type] => new [patent_app_number] => 10/417312 [patent_app_country] => US [patent_app_date] => 2003-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 32330 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20030235868.pdf [firstpage_image] =>[orig_patent_app_number] => 10417312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216403 [patent_doc_number] => 20040071696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Bispecific single chain Fv antibody molecules and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/406830 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22724 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20040071696.pdf [firstpage_image] =>[orig_patent_app_number] => 10406830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7382460 [patent_doc_number] => 20040029197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Novel human cancer/testis antigen and gene thereof' [patent_app_type] => new [patent_app_number] => 10/363791 [patent_app_country] => US [patent_app_date] => 2003-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12429 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029197.pdf [firstpage_image] =>[orig_patent_app_number] => 10363791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7303216 [patent_doc_number] => 20040115193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Internalizing anti-CD-74 antibodies and methods of use' [patent_app_type] => new [patent_app_number] => 10/377122 [patent_app_country] => US [patent_app_date] => 2003-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22584 [patent_no_of_claims] => 95 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115193.pdf [firstpage_image] =>[orig_patent_app_number] => 10377122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6739730 [patent_doc_number] => 20030157099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Human trk receptors and neurotrophic factor inhibitors' [patent_app_type] => new [patent_app_number] => 10/374469 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 33986 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157099.pdf [firstpage_image] =>[orig_patent_app_number] => 10374469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7397288 [patent_doc_number] => 20040038883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Peptide inhibitors of Akt and uses thereof' [patent_app_type] => new [patent_app_number] => 10/365348 [patent_app_country] => US [patent_app_date] => 2003-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 9981 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038883.pdf [firstpage_image] =>[orig_patent_app_number] => 10365348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711068 [patent_doc_number] => 20030170817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Anti-Fas antibodies' [patent_app_type] => new [patent_app_number] => 10/384933 [patent_app_country] => US [patent_app_date] => 2003-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 68488 [patent_no_of_claims] => 119 [patent_no_of_ind_claims] => 48 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170817.pdf [firstpage_image] =>[orig_patent_app_number] => 10384933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 432442 [patent_doc_number] => 07265216 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-04 [patent_title] => 'Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/357175 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 9892 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/265/07265216.pdf [firstpage_image] =>[orig_patent_app_number] => 10357175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 612928 [patent_doc_number] => 07148326 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-12 [patent_title] => 'Tumor antigen' [patent_app_type] => utility [patent_app_number] => 10/353929 [patent_app_country] => US [patent_app_date] => 2003-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 16269 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/148/07148326.pdf [firstpage_image] =>[orig_patent_app_number] => 10353929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851991 [patent_doc_number] => 20030144194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Cancer treatment and prognosis' [patent_app_type] => new [patent_app_number] => 10/204644 [patent_app_country] => US [patent_app_date] => 2003-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5748 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144194.pdf [firstpage_image] =>[orig_patent_app_number] => 10204644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6696812 [patent_doc_number] => 20030109006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Methods and compositions for generating human monoclonal antibodies' [patent_app_type] => new [patent_app_number] => 10/327423 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14833 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109006.pdf [firstpage_image] =>[orig_patent_app_number] => 10327423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7303227 [patent_doc_number] => 20040115204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Antibodies to treat cancer' [patent_app_type] => new [patent_app_number] => 10/318397 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20031 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115204.pdf [firstpage_image] =>[orig_patent_app_number] => 10318397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098440 [patent_doc_number] => 20050130899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Tumor antigens' [patent_app_type] => utility [patent_app_number] => 10/498075 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13221 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130899.pdf [firstpage_image] =>[orig_patent_app_number] => 10498075 [rel_patent_id] =>[rel_patent_doc_number] =>)